Status:
COMPLETED
The Effect of Early MSAT Treatment on Sciatica Caused by Traffic Accidents.
Lead Sponsor:
Jaseng Medical Foundation
Conditions:
Sciatica
Radiating Pain
Eligibility:
All Genders
19-69 years
Phase:
NA
Brief Summary
The investigators would like to conduct a pilot study prior to a practical randomized control study on the effectiveness of initial MSAT treatment on inpatients complaining of radiating pain and abnor...
Detailed Description
The stimulation of the nerve roots due to physicochemical causes can lead to symptoms along the distribution area of those nerves, such as radiating pain, numbness, a sensation of heat, dullness in se...
Eligibility Criteria
Inclusion
- a person who has no problem in language communication
- men and women between the ages of 19 and 69
- a patient hospitalized for treatment in a car accident
- A person who complains of radiating pain or abnormal sensation in the lower extremities within three days after a traffic accident
- A person with a lower extremity radiating pain or abnormal sensation of NRS (Numeric Rating Scale) 5 or higher
- A person who voluntarily agrees to participate in clinical trials and signs a consent form
Exclusion
- Patient diagnosed with certain serious diseases that may cause radiation pain: malignant tumors, spinal fractures, spinal infections, inflammatory spondylitis, etc
- Patient with progressive neurological deficits or severe neurological symptoms such as Mami syndrome
- Patient who has undergone surgery, procedures, or is scheduled to undergo surgery on the lumbar spine or lower extremities within the last 3 weeks
- Patient with other chronic conditions that may interfere with interpretation of treatment effects or results: cardiovascular disease, kidney disease, active hepatitis, diabetic neuropathy, dementia, severe mental illness, epilepsy, etc
- Patient who may be inadequate or unsafe with acupuncture treatment: hemorrhagic disease, people on anticoagulant therapy, people with severe cardiovascular disease, pregnancy, and infection Severe diabetic patients, seizure disorders, etc. that are concerned
- Patient currently taking steroids, immunosuppressants, mental illness medications or other medications that may affect research results
- Patient Participating in clinical trials other than observational studies without therapeutic intervention
- Patient who has difficulty filling out consent forms to participate in research
- Patient deemed difficult to conduct this clinical study when judged by the research director
Key Trial Info
Start Date :
October 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 15 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06179901
Start Date
October 30 2023
End Date
October 15 2024
Last Update
March 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jaseng Hospital of Korean Medicine
Seoul, Gangnam-Gu, South Korea, 135-896